| Code | Display |
| A |
ALIMENTARY TRACT AND METABOLISM |
| A01 |
STOMATOLOGICAL PREPARATIONS |
| A01A |
STOMATOLOGICAL PREPARATIONS |
| A01AA |
Caries prophylactic agents |
| A01AA01 |
sodium fluoride |
| A01AA02 |
sodium monofluorophosphate |
| A01AA03 |
olaflur |
| A01AA04 |
stannous fluoride |
| A01AA30 |
combinations |
| A01AA51 |
sodium fluoride, combinations |
| A01AB |
Antiinfectives and antiseptics for local oral treatment |
| A01AB02 |
hydrogen peroxide |
| A01AB03 |
chlorhexidine |
| A01AB04 |
amphotericin B |
| A01AB05 |
polynoxylin |
| A01AB06 |
domiphen |
| A01AB07 |
oxyquinoline |
| A01AB08 |
neomycin |
| A01AB09 |
miconazole |
| A01AB10 |
natamycin |
| A01AB11 |
various |
| A01AB12 |
hexetidine |
| A01AB13 |
tetracycline |
| A01AB14 |
benzoxonium chloride |
| A01AB15 |
tibezonium iodide |
| A01AB16 |
mepartricin |
| A01AB17 |
metronidazole |
| A01AB18 |
clotrimazole |
| A01AB19 |
sodium perborate |
| A01AB21 |
chlortetracycline |
| A01AB22 |
doxycycline |
| A01AB23 |
minocycline |
| A01AB24 |
octenidine |
| A01AB25 |
oxytetracycline |
| A01AB53 |
chlorhexidine and cetylpyridinium |
| A01AC |
Corticosteroids for local oral treatment |
| A01AC01 |
triamcinolone |
| A01AC02 |
dexamethasone |
| A01AC03 |
hydrocortisone |
| A01AC04 |
prednisolone |
| A01AC54 |
prednisolone, combinations |
| A01AD |
Other agents for local oral treatment |
| A01AD01 |
epinephrine |
| A01AD02 |
benzydamine |
| A01AD05 |
acetylsalicylic acid |
| A01AD06 |
adrenalone |
| A01AD07 |
amlexanox |
| A01AD08 |
becaplermin |
| A01AD11 |
various |
| A02 |
DRUGS FOR ACID RELATED DISORDERS |
| A02A |
ANTACIDS |
| A02AA |
Magnesium compounds |
| A02AA01 |
magnesium carbonate |
| A02AA02 |
magnesium oxide |
| A02AA03 |
magnesium peroxide |
| A02AA04 |
magnesium hydroxide |
| A02AA05 |
magnesium silicate |
| A02AA10 |
combinations |
| A02AB |
Aluminium compounds |
| A02AB01 |
aluminium hydroxide |
| A02AB02 |
algeldrate |
| A02AB03 |
aluminium phosphate |
| A02AB04 |
dihydroxialumini sodium carbonate |
| A02AB05 |
aluminium acetoacetate |
| A02AB06 |
aloglutamol |
| A02AB07 |
aluminium glycinate |
| A02AB10 |
combinations |
| A02AC |
Calcium compounds |
| A02AC01 |
calcium carbonate |
| A02AC02 |
calcium silicate |
| A02AC10 |
combinations |
| A02AD |
Combinations and complexes of aluminium, calcium and magnesium compounds |
| A02AD01 |
ordinary salt combinations |
| A02AD02 |
magaldrate |
| A02AD03 |
almagate |
| A02AD04 |
hydrotalcite |
| A02AD05 |
almasilate |
| A02AF |
Antacids with antiflatulents |
| A02AF01 |
magaldrate and antiflatulents |
| A02AF02 |
ordinary salt combinations and antiflatulents |
| A02AG |
Antacids with antispasmodics |
| A02AH |
Antacids with sodium bicarbonate |
| A02AX |
Antacids, other combinations |
| A02B |
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) |
| A02BA |
H2-receptor antagonists |
| A02BA01 |
cimetidine |
| A02BA02 |
ranitidine |
| A02BA03 |
famotidine |
| A02BA04 |
nizatidine |
| A02BA05 |
niperotidine |
| A02BA06 |
roxatidine |
| A02BA07 |
ranitidine bismuth citrate |
| A02BA08 |
lafutidine |
| A02BA51 |
cimetidine, combinations |
| A02BA53 |
famotidine, combinations |
| A02BB |
Prostaglandins |
| A02BB01 |
misoprostol |
| A02BB02 |
enprostil |
| A02BC |
Proton pump inhibitors |
| A02BC01 |
omeprazole |
| A02BC02 |
pantoprazole |
| A02BC03 |
lansoprazole |
| A02BC04 |
rabeprazole |
| A02BC05 |
esomeprazole |
| A02BC06 |
dexlansoprazole |
| A02BC07 |
dexrabeprazole |
| A02BC08 |
vonoprazan |
| A02BC09 |
tegoprazan |
| A02BC10 |
fexuprazan |
| A02BC11 |
ilaprazole |
| A02BC51 |
omeprazole, combinations |
| A02BC53 |
lansoprazole, combinations |
| A02BC54 |
rabeprazole, combinations |
| A02BD |
Combinations for eradication of Helicobacter pylori |
| A02BD01 |
omeprazole, amoxicillin and metronidazole |
| A02BD02 |
lansoprazole, tetracycline and metronidazole |
| A02BD03 |
lansoprazole, amoxicillin and metronidazole |
| A02BD04 |
pantoprazole, amoxicillin and clarithromycin |
| A02BD05 |
omeprazole, amoxicillin and clarithromycin |
| A02BD06 |
esomeprazole, amoxicillin and clarithromycin |
| A02BD07 |
lansoprazole, amoxicillin and clarithromycin |
| A02BD08 |
bismuth subcitrate, tetracycline and metronidazole |
| A02BD09 |
lansoprazole, clarithromycin and tinidazole |
| A02BD10 |
lansoprazole, amoxicillin and levofloxacin |
| A02BD11 |
pantoprazole, amoxicillin, clarithromycin and metronidazole |
| A02BD12 |
rabeprazole, amoxicillin and clarithromycin |
| A02BD13 |
rabeprazole, amoxicillin and metronidazole |
| A02BD14 |
vonoprazan, amoxicillin and clarithromycin |
| A02BD15 |
vonoprazan, amoxicillin and metronidazole |
| A02BD16 |
omeprazole, amoxicillin and rifabutin |
| A02BD17 |
vonoprazan and amoxicillin |
| A02BX |
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
| A02BX01 |
carbenoxolone |
| A02BX02 |
sucralfate |
| A02BX03 |
pirenzepine |
| A02BX04 |
methiosulfonium chloride |
| A02BX05 |
bismuth subcitrate |
| A02BX06 |
proglumide |
| A02BX07 |
gefarnate |
| A02BX08 |
sulglicotide |
| A02BX09 |
acetoxolone |
| A02BX10 |
zolimidine |
| A02BX11 |
troxipide |
| A02BX12 |
bismuth subnitrate |
| A02BX13 |
alginic acid |
| A02BX14 |
rebamipide |
| A02BX15 |
teprenone |
| A02BX16 |
irsogladine |
| A02BX51 |
carbenoxolone, combinations excl. psycholeptics |
| A02BX71 |
carbenoxolone, combinations with psycholeptics |
| A02BX77 |
gefarnate, combinations with psycholeptics |
| A02X |
OTHER DRUGS FOR ACID RELATED DISORDERS |
| A03 |
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03A |
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03AA |
Synthetic anticholinergics, esters with tertiary amino group |
| A03AA01 |
oxyphencyclimine |
| A03AA03 |
camylofin |
| A03AA04 |
mebeverine |
| A03AA05 |
trimebutine |
| A03AA06 |
rociverine |
| A03AA07 |
dicycloverine |
| A03AA08 |
dihexyverine |
| A03AA09 |
difemerine |
| A03AA30 |
piperidolate |
| A03AB |
Synthetic anticholinergics, quaternary ammonium compounds |
| A03AB01 |
benzilone |
| A03AB02 |
glycopyrronium bromide |
| A03AB03 |
oxyphenonium |
| A03AB04 |
penthienate |
| A03AB05 |
propantheline |
| A03AB06 |
otilonium bromide |
| A03AB07 |
methantheline |
| A03AB08 |
tridihexethyl |
| A03AB09 |
isopropamide |
| A03AB10 |
hexocyclium |
| A03AB11 |
poldine |
| A03AB12 |
mepenzolate |
| A03AB13 |
bevonium |
| A03AB14 |
pipenzolate |
| A03AB15 |
diphemanil |
| A03AB16 |
(2-benzhydryloxyethyl)diethyl-methylammonium iodide |
| A03AB17 |
tiemonium iodide |
| A03AB18 |
prifinium bromide |
| A03AB19 |
timepidium bromide |
| A03AB21 |
fenpiverinium |
| A03AB53 |
oxyphenonium, combinations |
| A03AC |
Synthetic antispasmodics, amides with tertiary amines |
| A03AC02 |
dimethylaminopropionylphenothiazine |
| A03AC04 |
nicofetamide |
| A03AC05 |
tiropramide |
| A03AD |
Papaverine and derivatives |
| A03AD01 |
papaverine |
| A03AD02 |
drotaverine |
| A03AD30 |
moxaverine |
| A03AE |
Serotonin receptor antagonists |
| A03AE01 |
alosetron |
| A03AE03 |
cilansetron |
| A03AX |
Other drugs for functional gastrointestinal disorders |
| A03AX01 |
fenpiprane |
| A03AX02 |
diisopromine |
| A03AX03 |
chlorbenzoxamine |
| A03AX04 |
pinaverium |
| A03AX05 |
fenoverine |
| A03AX06 |
idanpramine |
| A03AX07 |
proxazole |
| A03AX08 |
alverine |
| A03AX09 |
trepibutone |
| A03AX10 |
isometheptene |
| A03AX11 |
caroverine |
| A03AX12 |
phloroglucinol |
| A03AX13 |
silicones |
| A03AX14 |
valethamate |
| A03AX15 |
menthae piperitae aetheroleum |
| A03AX30 |
trimethyldiphenylpropylamine |
| A03AX58 |
alverine, combinations |
| A03B |
BELLADONNA AND DERIVATIVES, PLAIN |
| A03BA |
Belladonna alkaloids, tertiary amines |
| A03BA01 |
atropine |
| A03BA03 |
hyoscyamine |
| A03BA04 |
belladonna total alkaloids |
| A03BB |
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
| A03BB01 |
butylscopolamine |
| A03BB02 |
methylatropine |
| A03BB03 |
methylscopolamine |
| A03BB04 |
fentonium |
| A03BB05 |
cimetropium bromide |
| A03BB06 |
homatropine methylbromide |
| A03C |
ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS |
| A03CA |
Synthetic anticholinergic agents in combination with psycholeptics |
| A03CA01 |
isopropamide and psycholeptics |
| A03CA02 |
clidinium and psycholeptics |
| A03CA03 |
oxyphencyclimine and psycholeptics |
| A03CA04 |
otilonium bromide and psycholeptics |
| A03CA05 |
glycopyrronium bromide and psycholeptics |
| A03CA06 |
bevonium and psycholeptics |
| A03CA07 |
ambutonium and psycholeptics |
| A03CA08 |
diphemanil and psycholeptics |
| A03CA09 |
pipenzolate and psycholeptics |
| A03CA30 |
emepronium and psycholeptics |
| A03CA34 |
propantheline and psycholeptics |
| A03CB |
Belladonna and derivatives in combination with psycholeptics |
| A03CB01 |
methylscopolamine and psycholeptics |
| A03CB02 |
belladonna total alkaloids and psycholeptics |
| A03CB03 |
atropine and psycholeptics |
| A03CB04 |
homatropine methylbromide and psycholeptics |
| A03CB31 |
hyoscyamine and psycholeptics |
| A03CC |
Other antispasmodics in combination with psycholeptics |
| A03D |
ANTISPASMODICS IN COMBINATION WITH ANALGESICS |
| A03DA |
Synthetic anticholinergic agents in combination with analgesics |
| A03DA01 |
tropenzilone and analgesics |
| A03DA02 |
pitofenone and analgesics |
| A03DA03 |
bevonium and analgesics |
| A03DA04 |
ciclonium and analgesics |
| A03DA05 |
camylofin and analgesics |
| A03DA06 |
trospium and analgesics |
| A03DA07 |
tiemonium iodide and analgesics |
| A03DB |
Belladonna and derivatives in combination with analgesics |
| A03DB04 |
butylscopolamine and analgesics |
| A03DC |
Other antispasmodics in combination with analgesics |
| A03E |
ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS |
| A03EA |
Antispasmodics, psycholeptics and analgesics in combination |
| A03ED |
Antispasmodics in combination with other drugs |
| A03F |
PROPULSIVES |
| A03FA |
Propulsives |
| A03FA01 |
metoclopramide |
| A03FA02 |
cisapride |
| A03FA03 |
domperidone |
| A03FA04 |
bromopride |
| A03FA05 |
alizapride |
| A03FA06 |
clebopride |
| A03FA07 |
itopride |
| A03FA08 |
cinitapride |
| A03FA09 |
mosapride |
| A03FA10 |
acotiamide |
| A04 |
ANTIEMETICS AND ANTINAUSEANTS |
| A04A |
ANTIEMETICS AND ANTINAUSEANTS |
| A04AA |
Serotonin (5HT3) antagonists |
| A04AA01 |
ondansetron |
| A04AA02 |
granisetron |
| A04AA03 |
tropisetron |
| A04AA04 |
dolasetron |
| A04AA05 |
palonosetron |
| A04AA55 |
palonosetron, combinations |
| A04AD |
Other antiemetics |
| A04AD01 |
scopolamine |
| A04AD02 |
cerium oxalate |
| A04AD04 |
chlorobutanol |
| A04AD05 |
metopimazine |
| A04AD10 |
dronabinol |
| A04AD11 |
nabilone |
| A04AD12 |
aprepitant |
| A04AD13 |
casopitant |
| A04AD14 |
rolapitant |
| A04AD51 |
scopolamine, combinations |
| A04AD54 |
chlorobutanol, combinations |
| A05 |
BILE AND LIVER THERAPY |
| A05A |
BILE THERAPY |
| A05AA |
Bile acids and derivatives |
| A05AA01 |
chenodeoxycholic acid |
| A05AA02 |
ursodeoxycholic acid |
| A05AA03 |
cholic acid |
| A05AA04 |
obeticholic acid |
| A05AA05 |
ursodoxicoltaurine |
| A05AB |
Preparations for biliary tract therapy |
| A05AB01 |
nicotinyl methylamide |
| A05AX |
Other drugs for bile therapy |
| A05AX01 |
piprozolin |
| A05AX02 |
hymecromone |
| A05AX03 |
cyclobutyrol |
| A05AX04 |
maralixibat chloride |
| A05AX05 |
odevixibat |
| A05AX06 |
elafibranor |
| A05AX07 |
seladelpar |
| A05B |
LIVER THERAPY, LIPOTROPICS |
| A05BA |
Liver therapy |
| A05BA01 |
arginine glutamate |
| A05BA03 |
silymarin |
| A05BA04 |
citiolone |
| A05BA05 |
epomediol |
| A05BA06 |
ornithine oxoglurate |
| A05BA07 |
tidiacic arginine |
| A05BA08 |
glycyrrhizic acid |
| A05BA09 |
metadoxine |
| A05BA10 |
phospholipids |
| A05C |
DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION |
| A06 |
DRUGS FOR CONSTIPATION |
| A06A |
DRUGS FOR CONSTIPATION |
| A06AA |
Softeners, emollients |
| A06AA01 |
liquid paraffin |
| A06AA02 |
docusate sodium |
| A06AA51 |
liquid paraffin, combinations |
| A06AB |
Contact laxatives |
| A06AB01 |
oxyphenisatine |
| A06AB02 |
bisacodyl |
| A06AB03 |
dantron |
| A06AB04 |
phenolphthalein |
| A06AB05 |
castor oil |
| A06AB06 |
senna glycosides |
| A06AB07 |
cascara |
| A06AB08 |
sodium picosulfate |
| A06AB09 |
bisoxatin |
| A06AB20 |
contact laxatives in combination |
| A06AB30 |
contact laxatives in combination with belladonna alkaloids |
| A06AB52 |
bisacodyl, combinations |
| A06AB53 |
dantron, combinations |
| A06AB56 |
senna glycosides, combinations |
| A06AB57 |
cascara, combinations |
| A06AB58 |
sodium picosulfate, combinations |
| A06AC |
Bulk-forming laxatives |
| A06AC01 |
ispaghula (psylla seeds) |
| A06AC02 |
ethulose |
| A06AC03 |
sterculia |
| A06AC05 |
linseed |
| A06AC06 |
methylcellulose |
| A06AC07 |
triticum (wheat fibre) |
| A06AC08 |
polycarbophil calcium |
| A06AC51 |
ispaghula, combinations |
| A06AC53 |
sterculia, combinations |
| A06AC55 |
linseed, combinations |
| A06AD |
Osmotically acting laxatives |
| A06AD01 |
magnesium carbonate |
| A06AD02 |
magnesium oxide |
| A06AD03 |
magnesium peroxide |
| A06AD04 |
magnesium sulfate |
| A06AD10 |
mineral salts in combination |
| A06AD11 |
lactulose |
| A06AD12 |
lactitol |
| A06AD13 |
sodium sulfate |
| A06AD14 |
pentaerithrityl |
| A06AD15 |
macrogol |
| A06AD16 |
mannitol |
| A06AD17 |
sodium phosphate |
| A06AD18 |
sorbitol |
| A06AD19 |
magnesium citrate |
| A06AD21 |
sodium tartrate |
| A06AD61 |
lactulose, combinations |
| A06AD65 |
macrogol, combinations |
| A06AG |
Enemas |
| A06AG01 |
sodium phosphate |
| A06AG02 |
bisacodyl |
| A06AG03 |
dantron, incl. combinations |
| A06AG04 |
glycerol |
| A06AG06 |
oil |
| A06AG07 |
sorbitol |
| A06AG10 |
docusate sodium, incl. combinations |
| A06AG11 |
sodium lauryl sulfoacetate, incl. combinations |
| A06AG20 |
combinations |
| A06AH |
Peripheral opioid receptor antagonists |
| A06AH01 |
methylnaltrexone bromide |
| A06AH02 |
alvimopan |
| A06AH03 |
naloxegol |
| A06AH04 |
naloxone |
| A06AH05 |
naldemedine |
| A06AX |
Other drugs for constipation |
| A06AX01 |
glycerol |
| A06AX02 |
carbon dioxide producing drugs |
| A06AX03 |
lubiprostone |
| A06AX04 |
linaclotide |
| A06AX05 |
prucalopride |
| A06AX06 |
tegaserod |
| A06AX07 |
plecanatide |
| A06AX08 |
tenapanor |
| A06AX09 |
elobixibat |
| A07 |
ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS |
| A07A |
INTESTINAL ANTIINFECTIVES |
| A07AA |
Antibiotics |
| A07AA01 |
neomycin |
| A07AA02 |
nystatin |
| A07AA03 |
natamycin |
| A07AA04 |
streptomycin |
| A07AA05 |
polymyxin B |
| A07AA06 |
paromomycin |
| A07AA07 |
amphotericin B |
| A07AA08 |
kanamycin |
| A07AA09 |
vancomycin |
| A07AA10 |
colistin |
| A07AA11 |
rifaximin |
| A07AA12 |
fidaxomicin |
| A07AA13 |
rifamycin |
| A07AA51 |
neomycin, combinations |
| A07AA54 |
streptomycin, combinations |
| A07AB |
Sulfonamides |
| A07AB02 |
phthalylsulfathiazole |
| A07AB03 |
sulfaguanidine |
| A07AB04 |
succinylsulfathiazole |
| A07AC |
Imidazole derivatives |
| A07AC01 |
miconazole |
| A07AX |
Other intestinal antiinfectives |
| A07AX01 |
broxyquinoline |
| A07AX02 |
acetarsol |
| A07AX03 |
nifuroxazide |
| A07AX04 |
nifurzide |
| A07B |
INTESTINAL ADSORBENTS |
| A07BA |
Charcoal preparations |
| A07BA01 |
medicinal charcoal |
| A07BA51 |
medicinal charcoal, combinations |
| A07BB |
Bismuth preparations |
| A07BC |
Other intestinal adsorbents |
| A07BC01 |
pectin |
| A07BC02 |
kaolin |
| A07BC03 |
crospovidone |
| A07BC04 |
attapulgite |
| A07BC05 |
diosmectite |
| A07BC30 |
combinations |
| A07BC54 |
attapulgite, combinations |
| A07C |
ELECTROLYTES WITH CARBOHYDRATES |
| A07CA |
Oral rehydration salt formulations |
| A07D |
ANTIPROPULSIVES |
| A07DA |
Antipropulsives |
| A07DA01 |
diphenoxylate |
| A07DA02 |
opium |
| A07DA03 |
loperamide |
| A07DA04 |
difenoxin |
| A07DA05 |
loperamide oxide |
| A07DA06 |
eluxadoline |
| A07DA52 |
morphine, combinations |
| A07DA53 |
loperamide, combinations |
| A07E |
INTESTINAL ANTIINFLAMMATORY AGENTS |
| A07EA |
Corticosteroids acting locally |
| A07EA01 |
prednisolone |
| A07EA02 |
hydrocortisone |
| A07EA03 |
prednisone |
| A07EA04 |
betamethasone |
| A07EA05 |
tixocortol |
| A07EA06 |
budesonide |
| A07EA07 |
beclometasone |
| A07EB |
Antiallergic agents, excl. corticosteroids |
| A07EB01 |
cromoglicic acid |
| A07EC |
Aminosalicylic acid and similar agents |
| A07EC01 |
sulfasalazine |
| A07EC02 |
mesalazine |
| A07EC03 |
olsalazine |
| A07EC04 |
balsalazide |
| A07F |
ANTIDIARRHEAL MICROORGANISMS |
| A07FA |
Antidiarrheal microorganisms |
| A07FA01 |
lactic acid producing organisms |
| A07FA02 |
saccharomyces boulardii |
| A07FA03 |
escherichia coli |
| A07FA51 |
lactic acid producing organisms, combinations |
| A07X |
OTHER ANTIDIARRHEALS |
| A07XA |
Other antidiarrheals |
| A07XA01 |
albumin tannate |
| A07XA02 |
ceratonia |
| A07XA03 |
calcium compounds |
| A07XA04 |
racecadotril |
| A07XA06 |
crofelemer |
| A07XA51 |
albumin tannate, combinations |
| A08 |
ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| A08A |
ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| A08AA |
Centrally acting antiobesity products |
| A08AA01 |
phentermine |
| A08AA02 |
fenfluramine |
| A08AA03 |
amfepramone |
| A08AA04 |
dexfenfluramine |
| A08AA05 |
mazindol |
| A08AA06 |
etilamfetamine |
| A08AA07 |
cathine |
| A08AA08 |
clobenzorex |
| A08AA09 |
mefenorex |
| A08AA10 |
sibutramine |
| A08AA11 |
lorcaserin |
| A08AA12 |
setmelanotide |
| A08AA51 |
phentermine and topiramate |
| A08AA56 |
ephedrine, combinations |
| A08AA62 |
bupropion and naltrexone |
| A08AB |
Peripherally acting antiobesity products |
| A08AB01 |
orlistat |
| A08AX |
Other antiobesity drugs |
| A08AX01 |
rimonabant |
| A09 |
DIGESTIVES, INCL. ENZYMES |
| A09A |
DIGESTIVES, INCL. ENZYMES |
| A09AA |
Enzyme preparations |
| A09AA01 |
diastase |
| A09AA02 |
multienzymes (lipase, protease etc.) |
| A09AA03 |
pepsin |
| A09AA04 |
tilactase |
| A09AB |
Acid preparations |
| A09AB01 |
glutamic acid hydrochloride |
| A09AB02 |
betaine hydrochloride |
| A09AB03 |
hydrochloric acid |
| A09AB04 |
citric acid |
| A09AC |
Enzyme and acid preparations, combinations |
| A09AC01 |
pepsin and acid preparations |
| A09AC02 |
multienzymes and acid preparations |
| A10 |
DRUGS USED IN DIABETES |
| A10A |
INSULINS AND ANALOGUES |
| A10AB |
Insulins and analogues for injection, fast-acting |
| A10AB01 |
insulin (human) |
| A10AB02 |
insulin (beef) |
| A10AB03 |
insulin (pork) |
| A10AB04 |
insulin lispro |
| A10AB05 |
insulin aspart |
| A10AB06 |
insulin glulisine |
| A10AB30 |
combinations |
| A10AC |
Insulins and analogues for injection, intermediate-acting |
| A10AC01 |
insulin (human) |
| A10AC02 |
insulin (beef) |
| A10AC03 |
insulin (pork) |
| A10AC04 |
insulin lispro |
| A10AC30 |
combinations |
| A10AD |
Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting |
| A10AD01 |
insulin (human) |
| A10AD02 |
insulin (beef) |
| A10AD03 |
insulin (pork) |
| A10AD04 |
insulin lispro |
| A10AD05 |
insulin aspart |
| A10AD06 |
insulin degludec and insulin aspart |
| A10AD30 |
combinations |
| A10AE |
Insulins and analogues for injection, long-acting |
| A10AE01 |
insulin (human) |
| A10AE02 |
insulin (beef) |
| A10AE03 |
insulin (pork) |
| A10AE04 |
insulin glargine |
| A10AE05 |
insulin detemir |
| A10AE06 |
insulin degludec |
| A10AE07 |
insulin icodec |
| A10AE30 |
combinations |
| A10AE54 |
insulin glargine and lixisenatide |
| A10AE56 |
insulin degludec and liraglutide |
| A10AF |
Insulins and analogues for inhalation |
| A10AF01 |
insulin (human) |
| A10B |
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| A10BA |
Biguanides |
| A10BA01 |
phenformin |
| A10BA02 |
metformin |
| A10BA03 |
buformin |
| A10BB |
Sulfonylureas |
| A10BB01 |
glibenclamide |
| A10BB02 |
chlorpropamide |
| A10BB03 |
tolbutamide |
| A10BB04 |
glibornuride |
| A10BB05 |
tolazamide |
| A10BB06 |
carbutamide |
| A10BB07 |
glipizide |
| A10BB08 |
gliquidone |
| A10BB09 |
gliclazide |
| A10BB10 |
metahexamide |
| A10BB11 |
glisoxepide |
| A10BB12 |
glimepiride |
| A10BB31 |
acetohexamide |
| A10BC |
Sulfonamides (heterocyclic) |
| A10BC01 |
glymidine |
| A10BD |
Combinations of oral blood glucose lowering drugs |
| A10BD01 |
phenformin and sulfonylureas |
| A10BD02 |
metformin and sulfonylureas |
| A10BD03 |
metformin and rosiglitazone |
| A10BD04 |
glimepiride and rosiglitazone |
| A10BD05 |
metformin and pioglitazone |
| A10BD06 |
glimepiride and pioglitazone |
| A10BD07 |
metformin and sitagliptin |
| A10BD08 |
metformin and vildagliptin |
| A10BD09 |
pioglitazone and alogliptin |
| A10BD10 |
metformin and saxagliptin |
| A10BD11 |
metformin and linagliptin |
| A10BD12 |
pioglitazone and sitagliptin |
| A10BD13 |
metformin and alogliptin |
| A10BD14 |
metformin and repaglinide |
| A10BD15 |
metformin and dapagliflozin |
| A10BD16 |
metformin and canagliflozin |
| A10BD17 |
metformin and acarbose |
| A10BD18 |
metformin and gemigliptin |
| A10BD19 |
linagliptin and empagliflozin |
| A10BD20 |
metformin and empagliflozin |
| A10BD21 |
saxagliptin and dapagliflozin |
| A10BD22 |
metformin and evogliptin |
| A10BD23 |
metformin and ertugliflozin |
| A10BD24 |
sitagliptin and ertugliflozin |
| A10BD25 |
metformin, saxagliptin and dapagliflozin |
| A10BD26 |
metformin and lobeglitazone |
| A10BD27 |
metformin, linagliptin and empagliflozin |
| A10BD28 |
metformin and teneligliptin |
| A10BD29 |
sitagliptin and dapagliflozin |
| A10BD30 |
gemigliptin and dapagliflozin |
| A10BF |
Alpha glucosidase inhibitors |
| A10BF01 |
acarbose |
| A10BF02 |
miglitol |
| A10BF03 |
voglibose |
| A10BG |
Thiazolidinediones |
| A10BG01 |
troglitazone |
| A10BG02 |
rosiglitazone |
| A10BG03 |
pioglitazone |
| A10BG04 |
lobeglitazone |
| A10BH |
Dipeptidyl peptidase 4 (DPP-4) inhibitors |
| A10BH01 |
sitagliptin |
| A10BH02 |
vildagliptin |
| A10BH03 |
saxagliptin |
| A10BH04 |
alogliptin |
| A10BH05 |
linagliptin |
| A10BH06 |
gemigliptin |
| A10BH07 |
evogliptin |
| A10BH08 |
teneligliptin |
| A10BH51 |
sitagliptin and simvastatin |
| A10BH52 |
gemigliptin and rosuvastatin |
| A10BJ |
Glucagon-like peptide-1 (GLP-1) analogues |
| A10BJ01 |
exenatide |
| A10BJ02 |
liraglutide |
| A10BJ03 |
lixisenatide |
| A10BJ04 |
albiglutide |
| A10BJ05 |
dulaglutide |
| A10BJ06 |
semaglutide |
| A10BJ07 |
beinaglutide |
| A10BK |
Sodium-glucose co-transporter 2 (SGLT2) inhibitors |
| A10BK01 |
dapagliflozin |
| A10BK02 |
canagliflozin |
| A10BK03 |
empagliflozin |
| A10BK04 |
ertugliflozin |
| A10BK05 |
ipragliflozin |
| A10BK06 |
sotagliflozin |
| A10BK07 |
luseogliflozin |
| A10BK08 |
bexagliflozin |
| A10BK09 |
enavogliflozin |
| A10BX |
Other blood glucose lowering drugs, excl. insulins |
| A10BX01 |
guar gum |
| A10BX02 |
repaglinide |
| A10BX03 |
nateglinide |
| A10BX05 |
pramlintide |
| A10BX06 |
benfluorex |
| A10BX08 |
mitiglinide |
| A10BX15 |
imeglimin |
| A10BX16 |
tirzepatide |
| A10BX17 |
carfloglitazar |
| A10BX18 |
dorzagliatin |
| A10X |
OTHER DRUGS USED IN DIABETES |
| A10XA |
Aldose reductase inhibitors |
| A10XA01 |
tolrestat |
| A10XX |
Other drugs used in diabetes |
| A10XX01 |
teplizumab |
| A10XX02 |
donislecel |
| A11 |
VITAMINS |
| A11A |
MULTIVITAMINS, COMBINATIONS |
| A11AA |
Multivitamins with minerals |
| A11AA01 |
multivitamins and iron |
| A11AA02 |
multivitamins and calcium |
| A11AA03 |
multivitamins and other minerals, incl. combinations |
| A11AA04 |
multivitamins and trace elements |
| A11AB |
Multivitamins, other combinations |
| A11B |
MULTIVITAMINS, PLAIN |
| A11BA |
Multivitamins, plain |
| A11C |
VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO |
| A11CA |
Vitamin A, plain |
| A11CA01 |
retinol (vit A) |
| A11CA02 |
betacarotene |
| A11CB |
Vitamin A and D in combination |
| A11CC |
Vitamin D and analogues |
| A11CC01 |
ergocalciferol |
| A11CC02 |
dihydrotachysterol |
| A11CC03 |
alfacalcidol |
| A11CC04 |
calcitriol |
| A11CC05 |
colecalciferol |
| A11CC06 |
calcifediol |
| A11CC20 |
combinations |
| A11CC55 |
colecalciferol, combinations |
| A11D |
VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 |
| A11DA |
Vitamin B1, plain |
| A11DA01 |
thiamine (vit B1) |
| A11DA02 |
sulbutiamine |
| A11DA03 |
benfotiamine |
| A11DB |
Vitamin B1 in combination with vitamin B6 and/or vitamin B12 |
| A11E |
VITAMIN B-COMPLEX, INCL. COMBINATIONS |
| A11EA |
Vitamin B-complex, plain |
| A11EB |
Vitamin B-complex with vitamin C |
| A11EC |
Vitamin B-complex with minerals |
| A11ED |
Vitamin B-complex with anabolic steroids |
| A11EX |
Vitamin B-complex, other combinations |
| A11G |
ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS |
| A11GA |
Ascorbic acid (vitamin C), plain |
| A11GA01 |
ascorbic acid (vit C) |
| A11GB |
Ascorbic acid (vitamin C), combinations |
| A11GB01 |
ascorbic acid (vit C) and calcium |
| A11H |
OTHER PLAIN VITAMIN PREPARATIONS |
| A11HA |
Other plain vitamin preparations |
| A11HA01 |
nicotinamide |
| A11HA02 |
pyridoxine (vit B6) |
| A11HA03 |
tocopherol (vit E) |
| A11HA04 |
riboflavin (vit B2) |
| A11HA05 |
biotin |
| A11HA06 |
pyridoxal phosphate |
| A11HA07 |
inositol |
| A11HA08 |
tocofersolan |
| A11HA30 |
dexpanthenol |
| A11HA31 |
calcium pantothenate |
| A11HA32 |
pantethine |
| A11J |
OTHER VITAMIN PRODUCTS, COMBINATIONS |
| A11JA |
Combinations of vitamins |
| A11JB |
Vitamins with minerals |
| A11JC |
Vitamins, other combinations |
| A12 |
MINERAL SUPPLEMENTS |
| A12A |
CALCIUM |
| A12AA |
Calcium |
| A12AA01 |
calcium phosphate |
| A12AA02 |
calcium glubionate |
| A12AA03 |
calcium gluconate |
| A12AA04 |
calcium carbonate |
| A12AA05 |
calcium lactate |
| A12AA06 |
calcium lactate gluconate |
| A12AA07 |
calcium chloride |
| A12AA08 |
calcium glycerylphosphate |
| A12AA09 |
calcium citrate lysine complex |
| A12AA10 |
calcium glucoheptonate |
| A12AA11 |
calcium pangamate |
| A12AA13 |
calcium citrate |
| A12AA20 |
calcium (different salts in combination) |
| A12AA30 |
calcium laevulate |
| A12AX |
Calcium, combinations with vitamin D and/or other drugs |
| A12B |
POTASSIUM |
| A12BA |
Potassium |
| A12BA01 |
potassium chloride |
| A12BA02 |
potassium citrate |
| A12BA03 |
potassium hydrogentartrate |
| A12BA04 |
potassium hydrogencarbonate |
| A12BA05 |
potassium gluconate |
| A12BA30 |
potassium (different salts in combination) |
| A12BA51 |
potassium, combinations |
| A12C |
OTHER MINERAL SUPPLEMENTS |
| A12CA |
Sodium |
| A12CA01 |
sodium chloride |
| A12CA02 |
sodium sulfate |
| A12CB |
Zinc |
| A12CB01 |
zinc sulfate |
| A12CB02 |
zinc gluconate |
| A12CB03 |
zinc protein complex |
| A12CC |
Magnesium |
| A12CC01 |
magnesium chloride |
| A12CC02 |
magnesium sulfate |
| A12CC03 |
magnesium gluconate |
| A12CC04 |
magnesium citrate |
| A12CC05 |
magnesium aspartate |
| A12CC06 |
magnesium lactate |
| A12CC07 |
magnesium levulinate |
| A12CC08 |
magnesium pidolate |
| A12CC09 |
magnesium orotate |
| A12CC10 |
magnesium oxide |
| A12CC30 |
magnesium (different salts in combination) |
| A12CD |
Fluoride |
| A12CD01 |
sodium fluoride |
| A12CD02 |
sodium monofluorophosphate |
| A12CD51 |
fluoride, combinations |
| A12CE |
Selenium |
| A12CE01 |
sodium selenate |
| A12CE02 |
sodium selenite |
| A12CX |
Other mineral products |
| A13 |
TONICS |
| A13A |
TONICS |
| A14 |
ANABOLIC AGENTS FOR SYSTEMIC USE |
| A14A |
ANABOLIC STEROIDS |
| A14AA |
Androstan derivatives |
| A14AA01 |
androstanolone |
| A14AA02 |
stanozolol |
| A14AA03 |
metandienone |
| A14AA04 |
metenolone |
| A14AA05 |
oxymetholone |
| A14AA06 |
quinbolone |
| A14AA07 |
prasterone |
| A14AA08 |
oxandrolone |
| A14AA09 |
norethandrolone |
| A14AB |
Estren derivatives |
| A14AB01 |
nandrolone |
| A14AB02 |
ethylestrenol |
| A14AB03 |
oxabolone cipionate |
| A14B |
OTHER ANABOLIC AGENTS |
| A15 |
APPETITE STIMULANTS |
| A16 |
OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16A |
OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16AA |
Amino acids and derivatives |
| A16AA01 |
levocarnitine |
| A16AA02 |
ademetionine |
| A16AA03 |
glutamine |
| A16AA04 |
mercaptamine |
| A16AA05 |
carglumic acid |
| A16AA06 |
betaine |
| A16AA07 |
metreleptin |
| A16AB |
Enzymes |
| A16AB01 |
alglucerase |
| A16AB02 |
imiglucerase |
| A16AB03 |
agalsidase alfa |
| A16AB04 |
agalsidase beta |
| A16AB05 |
laronidase |
| A16AB06 |
sacrosidase |
| A16AB07 |
alglucosidase alfa |
| A16AB08 |
galsulfase |
| A16AB09 |
idursulfase |
| A16AB10 |
velaglucerase alfa |
| A16AB11 |
taliglucerase alfa |
| A16AB12 |
elosulfase alfa |
| A16AB13 |
asfotase alfa |
| A16AB14 |
sebelipase alfa |
| A16AB15 |
velmanase alfa |
| A16AB16 |
idursulfase beta |
| A16AB17 |
cerliponase alfa |
| A16AB18 |
vestronidase alfa |
| A16AB19 |
pegvaliase |
| A16AB20 |
pegunigalsidase alfa |
| A16AB21 |
atidarsagene autotemcel |
| A16AB22 |
avalglucosidase alfa |
| A16AB23 |
cipaglucosidase alfa |
| A16AB24 |
pegzilarginase |
| A16AB25 |
olipudase alfa |
| A16AB26 |
eladocagene exuparvovec |
| A16AB27 |
pabinafusp alfa |
| A16AX |
Various alimentary tract and metabolism products |
| A16AX01 |
thioctic acid |
| A16AX02 |
anethole trithione |
| A16AX03 |
sodium phenylbutyrate |
| A16AX04 |
nitisinone |
| A16AX05 |
zinc acetate |
| A16AX06 |
miglustat |
| A16AX07 |
sapropterin |
| A16AX08 |
teduglutide |
| A16AX09 |
glycerol phenylbutyrate |
| A16AX10 |
eliglustat |
| A16AX11 |
sodium benzoate |
| A16AX12 |
trientine |
| A16AX13 |
uridine triacetate |
| A16AX14 |
migalastat |
| A16AX15 |
telotristat |
| A16AX16 |
givosiran |
| A16AX17 |
triheptanoin |
| A16AX18 |
lumasiran |
| A16AX19 |
fosdenopterin |
| A16AX20 |
lonafarnib |
| A16AX21 |
elivaldogene autotemcel |
| A16AX22 |
tiomolibdic acid |
| A16AX23 |
leriglitazone |
| A16AX24 |
govorestat |
| A16AX25 |
nedosiran |
| A16AX30 |
sodium benzoate and sodium phenylacetate |
| B |
BLOOD AND BLOOD FORMING ORGANS |
| B01 |
ANTITHROMBOTIC AGENTS |
| B01A |
ANTITHROMBOTIC AGENTS |
| B01AA |
Vitamin K antagonists |
| B01AA01 |
dicoumarol |
| B01AA02 |
phenindione |
| B01AA03 |
warfarin |
| B01AA04 |
phenprocoumon |
| B01AA07 |
acenocoumarol |
| B01AA08 |
ethyl biscoumacetate |
| B01AA09 |
clorindione |
| B01AA10 |
diphenadione |
| B01AA11 |
tioclomarol |
| B01AA12 |
fluindione |
| B01AB |
Heparin group |
| B01AB01 |
heparin |
| B01AB02 |
antithrombin III |
| B01AB04 |
dalteparin |
| B01AB05 |
enoxaparin |
| B01AB06 |
nadroparin |
| B01AB07 |
parnaparin |
| B01AB08 |
reviparin |
| B01AB09 |
danaparoid |
| B01AB10 |
tinzaparin |
| B01AB11 |
sulodexide |
| B01AB12 |
bemiparin |
| B01AB51 |
heparin, combinations |
| B01AC |
Platelet aggregation inhibitors excl. heparin |
| B01AC01 |
ditazole |
| B01AC02 |
cloricromen |
| B01AC03 |
picotamide |
| B01AC04 |
clopidogrel |
| B01AC05 |
ticlopidine |
| B01AC06 |
acetylsalicylic acid |
| B01AC07 |
dipyridamole |
| B01AC08 |
carbasalate calcium |
| B01AC09 |
epoprostenol |
| B01AC10 |
indobufen |
| B01AC11 |
iloprost |
| B01AC13 |
abciximab |
| B01AC15 |
aloxiprin |
| B01AC16 |
eptifibatide |
| B01AC17 |
tirofiban |
| B01AC18 |
triflusal |
| B01AC19 |
beraprost |
| B01AC21 |
treprostinil |
| B01AC22 |
prasugrel |
| B01AC23 |
cilostazol |
| B01AC24 |
ticagrelor |
| B01AC25 |
cangrelor |
| B01AC26 |
vorapaxar |
| B01AC27 |
selexipag |
| B01AC28 |
limaprost |
| B01AC30 |
combinations |
| B01AC56 |
acetylsalicylic acid, combinations with proton pump inhibitors |
| B01AD |
Enzymes |
| B01AD01 |
streptokinase |
| B01AD02 |
alteplase |
| B01AD03 |
anistreplase |
| B01AD04 |
urokinase |
| B01AD05 |
fibrinolysin |
| B01AD06 |
brinase |
| B01AD07 |
reteplase |
| B01AD08 |
saruplase |
| B01AD09 |
ancrod |
| B01AD10 |
drotrecogin alfa (activated) |
| B01AD11 |
tenecteplase |
| B01AD12 |
protein C |
| B01AD13 |
apadamtase alfa and cinaxadamtase alfa |
| B01AE |
Direct thrombin inhibitors |
| B01AE01 |
desirudin |
| B01AE02 |
lepirudin |
| B01AE03 |
argatroban |
| B01AE04 |
melagatran |
| B01AE05 |
ximelagatran |
| B01AE06 |
bivalirudin |
| B01AE07 |
dabigatran etexilate |
| B01AF |
Direct factor Xa inhibitors |
| B01AF01 |
rivaroxaban |
| B01AF02 |
apixaban |
| B01AF03 |
edoxaban |
| B01AF04 |
betrixaban |
| B01AF51 |
rivaroxaban and acetylsalicylic acid |
| B01AX |
Other antithrombotic agents |
| B01AX01 |
defibrotide |
| B01AX04 |
dermatan sulfate |
| B01AX05 |
fondaparinux |
| B01AX07 |
caplacizumab |
| B02 |
ANTIHEMORRHAGICS |
| B02A |
ANTIFIBRINOLYTICS |
| B02AA |
Amino acids |
| B02AA01 |
aminocaproic acid |
| B02AA02 |
tranexamic acid |
| B02AA03 |
aminomethylbenzoic acid |
| B02AB |
Proteinase inhibitors |
| B02AB01 |
aprotinin |
| B02AB02 |
alfa1 antitrypsin |
| B02AB04 |
camostat |
| B02AB05 |
ulinastatin |
| B02B |
VITAMIN K AND OTHER HEMOSTATICS |
| B02BA |
Vitamin K |
| B02BA01 |
phytomenadione |
| B02BA02 |
menadione |
| B02BB |
Fibrinogen |
| B02BB01 |
fibrinogen, human |
| B02BC |
Local hemostatics |
| B02BC01 |
absorbable gelatin sponge |
| B02BC02 |
oxidized cellulose |
| B02BC03 |
tetragalacturonic acid hydroxymethylester |
| B02BC05 |
adrenalone |
| B02BC06 |
thrombin |
| B02BC07 |
collagen |
| B02BC08 |
calcium alginate |
| B02BC09 |
epinephrine |
| B02BC30 |
combinations |
| B02BD |
Blood coagulation factors |
| B02BD01 |
coagulation factor IX, II, VII and X in combination |
| B02BD02 |
coagulation factor VIII |
| B02BD03 |
factor VIII inhibitor bypassing activity |
| B02BD04 |
coagulation factor IX |
| B02BD05 |
coagulation factor VII |
| B02BD06 |
von Willebrand factor and coagulation factor VIII in combination |
| B02BD07 |
coagulation factor XIII |
| B02BD08 |
coagulation factor VIIa |
| B02BD10 |
von Willebrand factor |
| B02BD11 |
catridecacog |
| B02BD13 |
coagulation factor X |
| B02BD14 |
susoctocog alfa |
| B02BD15 |
valoctocogene roxaparvovec |
| B02BD16 |
etranacogene dezaparvovec |
| B02BD17 |
fidanacogene elaparvovec |
| B02BD30 |
thrombin |
| B02BX |
Other systemic hemostatics |
| B02BX01 |
etamsylate |
